RFA-EB-23-006: Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2023.
National Institutes of Health offered grants of up to $300,000 to colleges and universities. Applications closed on October 14, 2024.
From the official notice on Grants.gov, last changed October 15, 2024. Checked November 7, 2026.
- Award ceiling$300,000
- Cost sharingNot required
- Funding typeCooperative Agreement
About this NIH notice
- Activity codeUG3 / UH3
- Clinical trialsNot allowed
- Funded byNIBIB
- Median yearly award$427,750
- Typical project length3 years
- UG3, Exploratory/Developmental Phase I Cooperative Agreement. The first phase of a phased cooperative agreement. Moving on to the UH3 phase depends on meeting agreed milestones. Other open UG3 notices.
- UH3, Exploratory/Developmental Cooperative Agreement Phase II. The second phase of a phased cooperative agreement, usually following a UG3 or UH2 phase. Other open UH3 notices.
Projects funded under RFA-EB-23-006 were run by National Institute of Biomedical Imaging and Bioengineering (NIBIB, 4 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-EB-23-006 in the NIH Guide.
Key dates
| Posted | October 10, 2023 |
|---|---|
| Deadline | October 14, 2024 |
| Archived by Grants.gov | November 13, 2024 |
Who can apply
This opportunity was open to colleges and universities.
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See full Notice of Funding Opportunity for additional information on eligibility.
Is this a realistic fit?
- Projects NIH funded under this notice had a median yearly award of $427,750; it allows up to $300,000 per award.
- Most of the program's money (76% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
GL to update purpose after the NOFO is finalized. Develop plans to establish or enhance BME departments, interdisciplinary technology centers, and/or academic programs which may include:Support research and educational opportunities for trainees in bioengineering and technology development (Undergrad and/or Graduate)Plans for core technology facilities, maker space, data science centersFaculty recruitment, collaborative research programs, training, and partnershipsBuilding curriculum and course developmentInnovation and entrepreneurship programs Plans for sustainability of programs
Funded under RFA-EB-23-006 so far
NIH funded 4 projects under RFA-EB-23-006 in fiscal 2024 to 2026, at 4 institutions. The median yearly award was $427,750.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Center for Neurovascular Engineering Research and adVanced Education (NERVE) | North Carolina Agri & Tech St Univ | 2026 | $407,061 |
| Accelerating Biosensing Technologies at Winston-Salem State University and Partner Institutions | Winston-Salem State University | 2026 | $408,217 |
| Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at North Carolina Central University | North Carolina Central University | 2026 | $431,000 |
| Center for Research and Education in Multiscale Bioengineering, Bioimaging, and Biosensing | Delaware State University | 2026 | $437,999 |
Who has won Discovery and Applied Research for Technological Innovations to Improve Human Health grants before
From fiscal 2021 to 2025, Discovery and Applied Research for Technological Innovations to Improve Human Health (93.286) awarded $1.8 billion across 1,983 grant awards, an average of $886,380 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The General Hospital Corporation | Massachusetts | 75 | $83.5 million |
| The Johns Hopkins University | Maryland | 68 | $83.5 million |
| The Leland Stanford Junior University | California | 64 | $53.0 million |
| Brigham & Womens Hospital Inc | Massachusetts | 41 | $49.5 million |
| The Trustees of the University of Pennsylvania | Pennsylvania | 44 | $48.3 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-EB-23-006 still open?
No. It closed on October 14, 2024.
Who can apply for Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)?
National Institutes of Health accepted applications from colleges and universities. The notice adds further conditions, so read its eligibility section.
What is the deadline for Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)?
Closed October 14, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $300,000 each.
Who has been funded under RFA-EB-23-006?
NIH RePORTER lists 4 projects funded under RFA-EB-23-006 in fiscal 2024 to 2026, at 4 institutions. The most were at North Carolina Agri & Tech St Univ, Winston-Salem State University, North Carolina Central University.
Who has won Discovery and Applied Research for Technological Innovations to Improve Human Health grants before?
The largest recipients over five fiscal years were The General Hospital Corporation, The Johns Hopkins University, The Leland Stanford Junior University. The program made 1,983 awards worth $1.8 billion in that time.
Similar open grants
- Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required)
- NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
- Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
- Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)
- Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)